{"id":"cytoflavin-enteric-coated-tablet","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL2108130","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Cytoflavin contains succinic acid (a Krebs cycle intermediate), riboflavin (vitamin B2), and nicotinamide (vitamin B3), which work synergistically to improve mitochondrial function and ATP production. This combination helps restore cellular energy metabolism and provides antioxidant protection, particularly in conditions characterized by metabolic dysfunction or hypoxia.","oneSentence":"Cytoflavin is a combination drug that enhances cellular energy metabolism and reduces oxidative stress through its active components.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:08:18.480Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute ischemic stroke"},{"name":"Chronic cerebrovascular insufficiency"},{"name":"Metabolic encephalopathy"}]},"trialDetails":[{"nctId":"NCT05935787","phase":"PHASE3","title":"Cytoflavin in the Complex Rehabilitation of Stroke Patients","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-06-09","conditions":"Stroke","enrollment":240},{"nctId":"NCT03849664","phase":"PHASE3","title":"Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2017-06-02","conditions":"Cognitive Dysfunction","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Inosine+Nicotinamide+Riboflavin+Succinic Acid tablet"],"phase":"phase_3","status":"active","brandName":"Cytoflavin® enteric-coated tablet","genericName":"Cytoflavin® enteric-coated tablet","companyName":"POLYSAN Scientific & Technological Pharmaceutical Company","companyId":"polysan-scientific-technological-pharmaceutical-company","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cytoflavin is a combination drug that enhances cellular energy metabolism and reduces oxidative stress through its active components. Used for Acute ischemic stroke, Chronic cerebrovascular insufficiency, Metabolic encephalopathy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}